- Home
- RGA vs BAX Comparison
RGA vs BAX Comparison
Compare RGA & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGA
- BAX
- Stock Information
- Founded
- RGA 1973
- BAX 1931
- Country
- RGA United States
- BAX United States
- Employees
- RGA N/A
- BAX N/A
- Industry
- RGA Life Insurance
- BAX Medical/Dental Instruments
- Sector
- RGA Finance
- BAX Health Care
- Exchange
- RGA Nasdaq
- BAX Nasdaq
- Market Cap
- RGA 13.9B
- BAX 15.6B
- IPO Year
- RGA 1993
- BAX N/A
- Fundamental
- Price
- RGA $203.29
- BAX $30.49
- Analyst Decision
- RGA Buy
- BAX Buy
- Analyst Count
- RGA 14
- BAX 8
- Target Price
- RGA $227.69
- BAX $37.25
- AVG Volume (30 Days)
- RGA 408.3K
- BAX 3.5M
- Earning Date
- RGA 05-01-2025
- BAX 05-01-2025
- Dividend Yield
- RGA 1.75%
- BAX 2.23%
- EPS Growth
- RGA N/A
- BAX N/A
- EPS
- RGA 11.84
- BAX N/A
- Revenue
- RGA $21,030,000,000.00
- BAX $10,771,000,000.00
- Revenue This Year
- RGA $6.39
- BAX $8.06
- Revenue Next Year
- RGA $9.40
- BAX $4.19
- P/E Ratio
- RGA $17.17
- BAX N/A
- Revenue Growth
- RGA 1.82
- BAX 15.36
- 52 Week Low
- RGA $159.25
- BAX $26.25
- 52 Week High
- RGA $233.81
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- RGA 54.40
- BAX 47.96
- Support Level
- RGA $200.32
- BAX $29.72
- Resistance Level
- RGA $204.91
- BAX $31.04
- Average True Range (ATR)
- RGA 3.93
- BAX 0.72
- MACD
- RGA -0.75
- BAX -0.03
- Stochastic Oscillator
- RGA 43.04
- BAX 26.01
About RGA Reinsurance Group of America Incorporated
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.